logo
Select company
Select metric
$ -22.22MNet Income Common Stock
VS
Market
28
Sector
54
Industry
68
History
88
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ -22.22M
3/31/2025$ -28.23M
12/31/2024$ -29.67M
9/30/2024$ -23.86M
6/30/2024$ -24.61M
3/31/2024$ -21.67M
12/31/2023$ -21.43M
9/30/2023$ -19.28M
6/30/2023$ -39.06M
3/31/2023$ -73.89M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ -122.54M.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average Net Inc. Cmn. has been $ -61.12M.
  • The median Net Inc. Cmn. for Y-MABS THERAPEUTICS INC during this period was $ -40.67M
  • Y-MABS THERAPEUTICS INC reached its highest Net Inc. Cmn. over the past 5 years at $ -19.28M.
  • The lowest Net Inc. Cmn. recorded by Y-MABS THERAPEUTICS INC in the same timeframe $ -134.95M

Y-MABS THERAPEUTICS INC's Net Inc. Cmn. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. Cmn. Benchmarks
CompanyNet Inc. Cmn.
ADCT : ADC THERAPEUTICS SA $ -169.94MNKTR : NEKTAR THERAPEUTICS $ -122.27MKURA : KURA ONCOLOGY INC $ -197.17MLXRX : LEXICON PHARMACEUTICALS INC $ -120.62MTRDA : ENTRADA THERAPEUTICS INC $ -73.35MXOMA : XOMA ROYALTY CORP $ -12.39MSAGE : SAGE THERAPEUTICS INC $ -301.19MCDXS : CODEXIS INC $ -64.98MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -60.16MSGMO : SANGAMO THERAPEUTICS INC $ -64.59M

Similar metrics to Net Inc. Cmn.:

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

YMAB - Net Income Common Stock, Last 5 years

$ -134.95M

Minimum

Jun 30, 2022

$ -19.28M

Maximum

Sep 30, 2023

$ -61.12M

Average

$ -40.67M

Median

Net Inc. Cmn. Benchmark Analysis

 The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.27M with a standard deviation of $ 113.61M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.37K
min$ -354.46M
max$ 366.43M
average$ 9.27M
median$ -2.46M
std$ 113.61M